Douglas Bowman
Takeda Oncology (United States) · 23 works · 1,634 citations · h-index 9
Top works
- A Practical Guide to Whole Slide Imaging: A White Paper From the Digital Pathology Association
- Introduction to Digital Image Analysis in Whole-slide Imaging: A White Paper from the Digital Pathology Association
- MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to Aneuploidy
- Localization of Human TACC3 to Mitotic Spindles Is Mediated by Phosphorylation on Ser558 by Aurora A: A Novel Pharmacodynamic Method for Measuring Aurora A Activity
- Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
- Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics
- Phase I Assessment of New Mechanism-Based Pharmacodynamic Biomarkers for MLN8054, a Small-Molecule Inhibitor of Aurora A Kinase
- Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)
- Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association
- Using High Content Analysis for Pharmacodynamic Assays in Tissue
- Developing Robust High Content Assays
- A Sensitive IHC Method for Monitoring Autophagy-Specific Markers in Human Tumor Xenografts
- Colloquium: SBI 2 HCS/HCA Informatics and Data Analysis - Best Practices and Unmet Needs September 15, 2015
- Designing Metrics for High Content Assays
- A General Guide to Selecting and Setting Up a High Content Imaging Platform
- High Content Analysis for Tissue Samples
- High Content Analytics
- Basic High Content Assay Development
- Designing Robust Assays
- Phosphorylation of vimentin by Aurora A kinase: implications for the use of intermediate filaments as pharmacodynamic markers of Aurora A activity